2021 New Mexico Statutes
Chapter 61 - Professional and Occupational Licenses
Article 2 - Optometry
Section 61-2-10.2 - Designation of pharmaceutical agents; certification for use of certain agents. (Repealed effective July 1, 2024.)
A. Subject to the provisions of the Optometry Act, optometrists qualified and certified by the board may prescribe or administer all pharmaceutical agents for the diagnosis and treatment of disease of the eye or adnexa; provided that an optometrist:
(1) may prescribe hydrocodone and hydrocodone combination medications;
(2) may administer epinephrine auto-injections to counter anaphylaxis; and
(3) shall not prescribe any other controlled substance classified in Schedule I or II pursuant to the Controlled Substances Act [Chapter 30, Article 31 NMSA 1978].
B. The board shall issue certification for the use of pharmaceutical agents as set forth in Subsection A of this section to optometrists currently licensed by the board. To be certified, an optometrist shall submit to the board proof of having satisfactorily completed a course in pharmacology as applied to optometry, with particular emphasis on the administration of pharmaceutical agents for the purpose of examination of the human eye, and analysis of ocular functions and treatment of visual defects or abnormal conditions of the human eye and its adnexa. The course shall constitute a minimum of twenty hours of instruction in clinical pharmacology, including systemic pharmacology as applied to optometry, and shall be taught by an accredited institution approved by the board.
C. Applicants for licensure shall meet the requirements for certification in the use of pharmaceutical agents as set forth in the Optometry Act and shall successfully complete the board's examination in pharmaceutical agents prior to licensure.
D. The certification authorized by this section shall be displayed in a conspicuous place in the optometrist's principal office or place of business.
History: 1978 Comp., § 61-2-10.2, enacted by Laws 1995, ch. 20, § 5; 1996, ch. 59, § 1; 2015, ch. 131, § 3.
ANNOTATIONSDelayed repeals. — For delayed repeal of this section, see 61-2-18 NMSA 1978.
The 2015 amendment, effective June 19, 2015, provided optometrists with greater prescribing powers; in the catchline, after "Designation of", deleted "oral"; in the introductory sentence of Subsection A, after "prescribe or administer", deleted the remainder of the sentence, deleted Paragraphs (1) through (5) of Subsection A and added "all pharmaceutical agents for the diagnosis and treatment of disease of the eye or adnexa; provided that an optometrist:" to the introductory sentence of Subsection A; added new Paragraphs (1) through (3) of Subsection A; in Subsection B, after "certification for the use of", deleted "oral", after "licensed by the board", deleted "who are certified for the use of topical ocular pharmaceutical agents", and after "administration of", deleted "oral"; and in Subsection C, deleted "As of July 1, 1996, all", after "certification in the use of", deleted "diagnostic, topical therapeutic and oral", and after "board's examination in", deleted "diagnostic, topical and oral".
The 1996 amendment, effective May 15, 1996, inserted "qualified and certified by the board" in the introductory language of Subsection A, inserted "currently licensed by the board" in the first sentence of Subsection B, added Subsection C, and redesignated former Subsection C as Subsection D.
